硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 BCL2L2 抗体对
试剂盒

人 BCL2L2 抗体对

01AB01637

BCL2 like 2 (BCL2L2) is an anti-apoptotic member of the BCL-2 family that promotes cell survival by sequestering pro-apoptotic BH3-only proteins, thereby preventing mitochondrial outer membrane permeabilization and subsequent caspase activation. It is prominently expressed in the nervous system and testis, where it supports the survival of neurotrophin-dependent neurons and postmitotic Sertoli cells. BCL2L2 interacts with survival pathways such as NF-kappaB and TNFR1 signaling to block BAX-mediated apoptosis. Clinically, dysregulation of BCL2L2 is associated with cancer cell survival and therapeutic resistance. It is also linked to glioma susceptibility and oculopharyngeal muscular dystrophy, making it a significant target for the development of pro-apoptotic cancer therapies.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
BCL2L2,BCL2L2-PABPN1
基因别名
BCLW; KIAA0271
蛋白别名
BCL2 like 2,BCL2L2-PABPN1 readthrough; BCL2L2
UniProt
Q92843
物种
Human

产品详情

靶点名称
BCL2L2
蛋白名称
BCL2 like 2,BCL2L2-PABPN1 readthrough
蛋白别名
Bcl-2-like protein 2; Bcl2-L-2; Apoptosis regulator Bcl-W
靶点基因名
BCL2L2,BCL2L2-PABPN1
基因别名
BCLW; KIAA0271
UniProt
Q92843
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

BCL2 like 2 (BCL2L2) is an anti-apoptotic member of the BCL-2 family that promotes cell survival by sequestering pro-apoptotic BH3-only proteins, thereby preventing mitochondrial outer membrane permeabilization and subsequent caspase activation. It is prominently expressed in the nervous system and testis, where it supports the survival of neurotrophin-dependent neurons and postmitotic Sertoli cells. BCL2L2 interacts with survival pathways such as NF-kappaB and TNFR1 signaling to block BAX-mediated apoptosis. Clinically, dysregulation of BCL2L2 is associated with cancer cell survival and therapeutic resistance. It is also linked to glioma susceptibility and oculopharyngeal muscular dystrophy, making it a significant target for the development of pro-apoptotic cancer therapies.